Reduce CV Event Risk with Urate-Lowering Therapy for Gout, suggests a study published in The Lancet Rheumatology.Researchers ...

XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA), a late stage clinical ...

Among patients with gout in the US, Black individuals and those living in the South were associated with reduced adherence to allopurinol.

A recent study by researchers from the University of California San Diego and collaborators has uncovered a new molecular ...

Limitations to the study included a lack of serum urate measurements and the potential for residual confounding; people's ...

The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. | Following some ...